Alisa Lask
Vermogen: 4 020 $ op 31-05-2026
Vermogen: 4 020 $ op 31-05-2026
Ms. Alisa Lask is a Chief Executive Officer & Director at Rion Aesthetics, Inc., a Chief Commercial Officer at Rion, Inc. and an Independent Director at CollPlant Biotechnologies Ltd. She is on the Board of Directors at Rion Aesthetics, Inc. and CollPlant Biotechnologies Ltd. Ms. Lask was previously employed as an Independent Director by RVL Pharmaceuticals Plc, an Independent Director by Nephros, Inc., a Vice President & General Manager-US Aesthetics by Galderma Laboratories LP, a Senior Director-Global Strategic Marketing by Allergan, Inc., a Vice President-Global Strategic Marketing by Zimmer Biomet, Inc., and a Director-Global Neuroscience by Eli Lilly & Co. She received her undergraduate degree from Miami University and an MBA from Stephen M.
Ross School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 10.000 ( 0,07% ) | 4 020 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Directeur/Bestuurslid | 19-08-2021 |
Rion, Inc.
Rion, Inc. BiotechnologyHealth Technology Operates as biotechnology company, which develops regenerative medicines | Corporate Officer/Principal | 01-11-2021 |
Rion Aesthetics, Inc.
Rion Aesthetics, Inc. Household/Personal CareConsumer Non-Durables Develops skin care products | Algemeen Directeur | 01-01-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| NEPHROS, INC. | Directeur/Bestuurslid | 16-06-2025 |
| RVL PHARMACEUTICALS PLC | Directeur/Bestuurslid | 23-10-2023 |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Corporate Officer/Principal | 01-06-2021 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01-06-2014 |
Zimmer US, Inc.
Zimmer US, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes orthopaedic reconstructive implants | Corporate Officer/Principal | 01-02-2010 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Nephros, Inc.
Nephros, Inc. Medical SpecialtiesHealth Technology Develops and sells performance liquid purification filters used blood purification and other medical devices | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Health Technology |
Rion, Inc.
Rion, Inc. BiotechnologyHealth Technology Operates as biotechnology company, which develops regenerative medicines | Health Technology |
CollPlant Biotechnologies Ltd.
CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zimmer US, Inc.
Zimmer US, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes orthopaedic reconstructive implants | Health Technology |
RVL Pharmaceuticals Plc
RVL Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
Rion Aesthetics, Inc.
Rion Aesthetics, Inc. Household/Personal CareConsumer Non-Durables Develops skin care products | Consumer Non-Durables |
Kies jouw editie
Alle financiële informatie op nationaal niveau